{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    23,
    24,
    25,
    26,
    27
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "8",
        "name": "Amendment 8",
        "scope": {
          "id": "3281bbca-259a-4dd6-95ea-6d979a6be50b",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "a6356282-47e1-4e96-8e5d-b356ccc57e2e",
          "code": {
            "id": "5d750945-5e01-40e7-ba8b-99fc36f81a9f",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "df978add-0f56-4136-b7d0-06a751988266",
            "type": {
              "id": "732d5142-9279-4f00-b8fa-7ad95acd4165",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reason for preparation of this amendment was to update the schedule of laboratory assessments following the IA3 cut-off date (28-Apr-2020) and to reflect changes in the collection of irRECIST-defined antitumor activity as per PACL dated 02 September 2019.",
        "effectiveDate": "2020-01-03",
        "reasonIds": [
          "ar_1_1",
          "ar_1_2"
        ],
        "previousVersion": "7",
        "newVersion": "8"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_1_2",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "United States",
        "instanceType": "Country",
        "code": "US"
      },
      {
        "id": "country_2",
        "name": "Canada",
        "instanceType": "Country",
        "code": "CA"
      },
      {
        "id": "country_3",
        "name": "Western Europe",
        "instanceType": "Country",
        "code": "EU"
      }
    ],
    "studySites": [],
    "summary": {
      "amendmentCount": 1,
      "countryCount": 3,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Global",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1",
        "country_2",
        "country_3"
      ],
      "regions": [
        "North America",
        "Western Europe",
        "Rest of the World"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "8",
        "effectiveDate": "2020-01-03",
        "summary": "The main reason for preparation of this amendment was to update the schedule of laboratory assessments following the IA3 cut-off date (28-Apr-2020) and to reflect changes in the collection of irRECIST-defined antitumor activity as per PACL dated 02 September 2019.",
        "previousVersion": "7",
        "newVersion": "8",
        "reasons": [
          "Operational",
          "Administrative"
        ]
      }
    ],
    "geographicScope": {
      "type": "Global",
      "countries": [
        {
          "name": "United States",
          "code": "US"
        },
        {
          "name": "Canada",
          "code": "CA"
        },
        {
          "name": "Western Europe",
          "code": "EU"
        }
      ],
      "regions": [
        "North America",
        "Western Europe",
        "Rest of the World"
      ],
      "plannedSites": null
    },
    "sites": []
  }
}